Participants 178 434 6
Twenty-eight newly diagnosed patients with small cell lung cancer were randomized to receive either high-dose or standard-dose cyclophosphamide, vincristine, and semustine in a trial where the dose of induction chemotherapy was the sole treatment variable.
Participants 954 1023 3
These effects were most pronounced in patients with extensive disease
